Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours

The feasibility of cancer immunotherapy mediated by T lymphocytes is now a clinical reality. Indeed, many tumour associated antigens have been identified for cytotoxic CD8 T cells, which are believed to be key mediators of tumour rejection. However, for aggressive malignancies in specialised anatomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoepner, Sabine, Loh, Jacelyn M. S., Riccadonna, Cristina, Derouazi, Madiha, Maroun, Céline Yacoub, Dietrich, Pierre-Yves, Walker, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662716/
https://www.ncbi.nlm.nih.gov/pubmed/23717511
http://dx.doi.org/10.1371/journal.pone.0063933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662716/
https://www.ncbi.nlm.nih.gov/pubmed/23717511
http://dx.doi.org/10.1371/journal.pone.0063933

Ejemplares similares